Successful transformation into a product company in 2018 with a promising outlook for 2019

c-LEcta continued its successful development towards becoming a product company in fiscal year 2018. Successful products marketed by c-LEcta itself...

read more


c-LEcta accelerates distribution of DENARASE® and signs sales agreement with VWR

To continue its growth strategy, c-LEcta is further expanding its track record in the commercialization of its products. In addition to the recent...

read more


c-LEcta lays foundation for further growth and closes financing round

c-LEcta already has a diversified shareholder structure. In addition to the founder, Dr. Marc Struhalla, private industrial investors and German...

read more


c-LEcta presented its Bacillus Expression Platform at WCIB 2018

This year’s BIO World Congress on Industrial Biotechnology took place in Philadelphia. Over 1,000 global business leaders, investors and policy makers...

read more


c-LEcta and leading ingredient company develop process to expand production of plant-based sweetener with sugar-like taste

The German-based expert for industrial biotechnology applications c-LEcta, in cooperation with a leading ingredient supplier, developed a process...

read more


c-LEcta Reports Financial Results of Business Year 2017

The Leipzig-based industrial biotechnology company has recently closed its financial accounts for last year with very positive outcomes. The company...

read more


EU Approval and Production of c-LEcta’s Trehalose Product TreXalose

For its new product TreXaloseTM c-LEcta has reached two important milestones: For the market introduction in Europe the substantial equivalence of...

read more


c-LEcta’s Production Facilities are Certified Kosher and Halal Now

After accomplishing several successful projects with global players from the food industry, the upcoming international market launch of the...

read more


c-LEcta Closes Exclusive Supply Agreement with Global Pharma Company

As a result of several years of successful collaboration in the field of biocatalysis, c-LEcta and a global leading producer of generic APIs have now...

read more